Portland, United States
Phylos, founded in 2014, positions itself at the intersection of Agriculture and Biotechnology, with a mission to unlock the potential of cannabis and hemp through data-driven science. The company focuses on providing growers with the tools they need to achieve commercial success through its industry-first Production-Ready Seed™. These seeds boast premium, phenotypically stable, fully-feminized F1 hybrid characteristics, ensuring exceptional flower quality, potency, vigor, and yield.
The company's expertise in cultivation, extraction, and formulation is further evidenced by its proprietary technologies that offer partners exclusive access to unparalleled THCV genetics and effective ingredient solutions. As of July 24, 2024, Phylos secured a $1.00M Convertible Note investment from OrganiGram, signaling a strong vote of confidence from established players within the industry. Headquartered in the United States, Phylos is poised to continue its impact within the expanding cannabis market.
